Recombinant Human ATP-sensitive inward rectifier potassium channel 1 (KCNJ1)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Human ATP-sensitive Inward Rectifier Potassium Channel 1 (KCNJ1)

The Recombinant Human ATP-sensitive Inward Rectifier Potassium Channel 1, also known as KCNJ1, is a protein that plays a vital role in potassium homeostasis, particularly within the kidneys . Inward rectifier potassium channels, such as KCNJ1, facilitate a greater flow of potassium into the cell compared to its outflow . The KCNJ1 gene encodes for the Kir1.1 protein, also known as the renal outer medullary K (ROMK) channel, found predominantly in the renal tubules .

Gene and Protein Characteristics

The KCNJ1 gene is located on chromosome 11 in humans . The protein encoded by KCNJ1 is an ATP-regulated potassium channel, which is also referred to as an inward rectifier K(+) channel or Kir1.1 . The molecular weight of the recombinant protein is approximately 28.3kDa .

Function and Mechanism

KCNJ1's function is significant in maintaining potassium balance within the body . It is involved in the recycling of potassium into the tubule lumen to energize the Na-K-2Cl co-transporter (NKCC2), which is essential for NaCl reabsorption . In the connecting tubule and collecting duct, KCNJ1 mediates potassium secretion and is electrically coupled with sodium reabsorption . The channel's voltage dependence is regulated by extracellular potassium concentrations; higher external potassium levels shift the channel opening to more positive voltages . The inward rectification is due to the blockage of outward current by internal magnesium . KCNJ1 is activated by internal ATP and can be blocked by external barium .

Clinical Significance

Mutations in the KCNJ1 gene have been associated with Bartter's syndrome, a salt-wasting tubulopathy . KCNJ1 is also considered a gene protective of hypertension in the general population .

Research and Studies

StudyFindings
Bock, J.H., et al., Gene (1997) Nucleotide sequence analysis of the human KCNJ1 potassium channel locus.
Hebert, S.C. Curr. Opin. Nephrol. Hypertens.(2003) Established the genetic heterogeneity of Bartter's syndrome and demonstrated the physiologic role of ROMK in vivo.
Krishnan, S.N., et al., Hum. Genet.(1995) Isolation and chromosomal localization of a human ATP-regulated potassium channel.
Cope, G., et al., J. Am. Soc. Nephrol.(2006) Showed that WNK1 affects surface expression of the ROMK potassium channel independent of WNK4.
Henderson, R.M., et al., Proc. Natl. Acad. Sci. U.S.A.(1996) Imaged ROMK1 inwardly rectifying ATP-sensitive K+ channel protein using atomic force microscopy.
Yano, H., et al., Mol. Pharmacol.(1994) Studied alternative splicing of human inwardly rectifying K+ channel ROMK1 mRNA.
Peters, M., et al. (2006) Studied the clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies.
Cho, J.T., Guay-Woodford, L.M. J. Korean Med. Sci.(2003) Reported heterozygous mutations of the gene for Kir 1.1 (ROMK) in antenatal Bartter syndrome presenting with transient hyperkalemia, evolving to a benign course.
Liu, X., Singh, B.B., Ambudkar, I.S. J. Biol. Chem.(1999) Studied ATP-dependent activation of K(Ca) and ROMK-type K(ATP) channels in human submandibular gland ductal cells.
Cader, Z.M., et al. Hum. Mol. Genet.(2003) Linked migraine with aura on chromosome 11q24.
Vollmer, M., et al. Pediatr. Nephrol.(1998) Identified two novel mutations of the gene for Kir 1.1 (ROMK) in neonatal Bartter syndrome.
Lin, D., et al. J. Biol. Chem.(2002) Protein kinase C (PKC)-induced phosphorylation of ROMK1 is essential for the surface expression of ROMK1 channels.
Xu, Z.C., et al. J. Biol. Chem.(1996) Studied phosphorylation of the ATP-sensitive, inwardly rectifying K+ channel, ROMK, by cyclic AMP-dependent protein kinase.
Kahle, K.T., et al. Proc. Natl. Acad. Sci. U.S.A.(2004) Showed that WNK4 regulates apical and basolateral Cl- flux in extrarenal epithelia.
Leng, Q., et al. J. Physiol. (Lond.)(2006) Found that WNK3, a kinase related to genes mutated in hereditary hypertension with hyperkalaemia, regulates the K+ channel ROMK1 (Kir1.1).
Gamba, G. Am. J. Physiol. Renal Physiol.(2005) Discussed the role of WNK kinases in regulating tubular salt and potassium transport and in the development of hypertension.
Konrad, M., et al. Pediatrics(1999) Reported prenatal and postnatal management of hyperprostaglandin E syndrome after genetic diagnosis from amniocytes.
Sterling, H., et al. Am. J. Physiol. Renal Physiol.(2003) Found that tetanus toxin abolishes exocytosis of ROMK1 induced by inhibition of protein tyrosine kinase.
O'Connell, A.D., et al. Proc. Natl. Acad. Sci. U.S.A.(2005) Phosphorylation-regulated endoplasmic reticulum retention signal in the renal outer-medullary K+ channel (ROMK).
Yoo, D., et al. J. Biol. Chem.(2004) Studied assembly and trafficking of a multiprotein ROMK (Kir 1.1) channel complex by PDZ interactions.
Pabon, A., et al. J. Biol. Chem.(2000) Glycosylation of GIRK1 at Asn119 and ROMK1 at Asn117 has different consequences in potassium channel function.
Károlyi, L., et al. J. Mol. Med.(1998) Discussed the molecular genetic approach to "Bartter's syndrome".
Cope, G., et al. Pharmacol. Ther.(2005) WNK kinases and the control of blood pressure.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order remarks for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50%, provided as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag type is determined during production. If you require a specific tag, please inform us for prioritized development.
Synonyms
ATP regulated potassium channel ROM K; ATP sensitive inward rectifier potassium channel 1; ATP-regulated potassium channel ROM-K; ATP-sensitive inward rectifier potassium channel 1; Inward rectifier K(+) channel Kir1.1; inwardly rectifying K+ channel ; inwardly rectifying subfamily J member 1; IRK1_HUMAN; KCNJ 1; KCNJ; Kcnj1; Kir 1.1; Kir1.1; OTTHUMP00000045938; Potassium channel; Potassium channel inwardly rectifying subfamily J member 1; potassium inwardly-rectifying channel J1; ROMK 1; ROMK 2; ROMK; ROMK1; ROMK2
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-391
Protein Length
Full length protein
Species
Homo sapiens (Human)
Target Names
KCNJ1
Target Protein Sequence
MNASSRNVFDTLIRVLTESMFKHLRKWVVTRFFGHSRQRARLVSKDGRCNIEFGNVEAQS RFIFFVDIWTTVLDLKWRYKMTIFITAFLGSWFFFGLLWYAVAYIHKDLPEFHPSANHTP CVENINGLTSAFLFSLETQVTIGYGFRCVTEQCATAIFLLIFQSILGVIINSFMCGAILA KISRPKKRAKTITFSKNAVISKRGGKLCLLIRVANLRKSLLIGSHIYGKLLKTTVTPEGE TIILDQININFVVDAGNENLFFISPLTIYHVIDHNSPFFHMAAETLLQQDFELVVFLDGT VESTSATCQVRTSYVPEEVLWGYRFAPIVSKTKEGKYRVDFHNFSKTVEVETPHCAMCLY NEKDVRARMKRGYDNPNFILSEVNETDDTKM
Uniprot No.

Target Background

Function

In the kidney, KCNJ1 (ROMK) likely plays a crucial role in potassium homeostasis. Inward rectifier potassium channels, such as ROMK, exhibit a preference for potassium influx over efflux. Their voltage dependence is modulated by extracellular potassium concentration; increasing external potassium shifts the channel opening voltage range to more positive potentials. Inward rectification primarily results from internal magnesium blockage of outward current. This channel is activated by intracellular ATP and can be inhibited by extracellular barium.

Gene References Into Functions
  1. Our whole-exome sequencing study confirmed the protective effects of SLC12A3, SLC12A1, and KCNJ1 against hypertension in the general population, replicating findings from a previous study identifying rare, potentially loss-of-function variants in these genes associated with reduced blood pressure. PMID: 30113482
  2. Immunofluorescence and subcellular fractionation studies demonstrated ROMK protein presence in the inner mitochondrial membrane and colocalization with mitochondrial markers in fibroblast mitochondria. PMID: 29458000
  3. Evidence suggests that the pathology underlying some Type II Bartter syndrome cases is linked to ROMK1 stability within the ERAD pathway. Using a yeast expression system, it was shown that wild-type (rat) ROMK1, but not ROMK1 variants containing four mutations found in human Type II Bartter syndrome, rescued cells. These mutant ROMKs exhibited significantly reduced stability compared to the wild-type. (ERAD = endoplasmic reticulum-associated degradation) PMID: 28630040
  4. WNK4, a substrate of SFKs, interacts with c-Src and PTP-1D at Tyr(1092) and Tyr(1143), significantly modulating WNK4's inhibitory effect on ROMK. PMID: 25805816
  5. KCNJ1 knockdown in HK-2 cells stimulated cell proliferation, indicating its crucial role in ccRCC cell growth and metastasis, with low expression correlating to poor prognosis. PMID: 25344677
  6. A study investigated the association between polymorphisms in KCNJ1, SLC12A1, and seven other genes with calcium intake and colorectal neoplasia risk. PMID: 25165391
  7. A KCNJ1 SNP was associated with increased fractional excretion of potassium (FEK) during hydrochlorothiazide (HCTZ) treatment. PMID: 22907731
  8. Molecular analysis of a Bartter syndrome patient revealed a compound heterozygous mutation in KCNJ1, comprising a novel K76E and a previously described V315G mutation, both impacting channel protein functional domains. PMID: 23782368
  9. Findings suggest that 11q24 is a susceptibility locus for openness, with KCNJ1 as a potential candidate gene. PMID: 23211697
  10. No KCNJ1 mutations were identified in patients with Bartter and Gitelman syndromes. PMID: 21631963
  11. PI3K-activating hormones inhibit ROMK by promoting its endocytosis through Akt1 and SGK1-mediated phosphorylation of WNK1. PMID: 21355052
  12. THGP modulation of ROMK function suggests a novel role in renal ion transport, potentially contributing to the salt wasting observed in FJHN/MCKD-2/GCKD patients. PMID: 21081491
  13. KCNJ1 mutations are associated with Bartter syndrome. PMID: 20219833
  14. ROMK1 is a PKC substrate; serine residues 4 and 201 are crucial PKC phosphorylation sites for cell surface ROMK1 expression. PMID: 12221079
  15. A disease-causing mutation in the ROMK channel truncates the extreme COOH-terminus, inducing a closed gating conformation. PMID: 12381810
  16. In a heterozygous Bartter syndrome patient, Arg338Stop and Met357Thr mutations in ROMK exon 5 altered the C-terminus, potentially affecting channel function. PMID: 12589089
  17. Findings support ROMK channels' role in potassium recycling and regulation of K+ secretion, providing a rationale for the phenotype observed in ROMK deficiency. PMID: 15895241
  18. N-terminal phosphorylation modifying a C-terminal ER retention signal in ROMK1 may serve as a checkpoint for proper subunit folding crucial for channel gating. PMID: 15987778
  19. ROMK is antagonistically regulated by long and kidney-specific WNK1 isoforms. PMID: 16428287
  20. A molecular mechanism for WNK kinase-mediated stimulation of ROMK1 endocytosis has been described. PMID: 17380208
  21. A novel KCNJ1 mutation was identified in a Bartter syndrome case initially diagnosed as pseudohypoaldosteronism. PMID: 17401586
  22. CD63 regulates ROMK channels through its interaction with RPTPα, which in turn activates Src family PTKs, reducing ROMK activity. PMID: 18211905
  23. The Framingham Heart Study screened for variations in SLC12A3, SLC12A1, and KCNJ1, genes associated with rare recessive diseases causing significant blood pressure reductions. PMID: 18391953
  24. Five KCNJ1 polymorphisms were associated with mean 24-hour systolic or diastolic blood pressure. PMID: 18443236
  25. Multiple intra- and intermolecular interactions of WNK1 domains are involved in WNK1 regulation of ROMK1 in the kidney. PMID: 18550644
  26. Results confirm the crucial role of the WNK4 acidic motif in its interaction with the ROMK channel. PMID: 18755144
  27. In a large cohort of antenatal/neonatal Bartter syndrome, deafness, transient hyperkalemia, and severe hypokalemic hypochloremic alkalosis guided molecular investigations towards BSND, KCNJ1, and CLCNKB genes. PMID: 19096086
  28. Cytoplasmic hydrophobic leucines in the inner transmembrane helices form the principal pH gate of Kir1.1, a gate relocatable from 160-Kir1.1b to 157-Kir1.1b. PMID: 19170254
  29. KS-WNK1 is a key physiological regulator of renal K+ excretion, likely through its effects on the ROMK1 channel. PMID: 19244242
  30. The cytoplasmic pore conformation in the Kir1.1 channel changes in response to pH gating; N- and C-termini move apart at pH 7.4, when the channel is open. PMID: 19272129
  31. Klotho regulates renal outer medullary potassium channel and renal K+ excretion. PMID: 19349416
  32. c-Src inhibits SGK1-mediated phosphorylation, restoring WNK4-mediated inhibition of ROMK channels and suppressing K+ secretion. PMID: 19706464
  33. POSH inhibits ROMK channels by enhancing dynamin-dependent and clathrin-independent endocytosis and stimulating ROMK channel ubiquitination. PMID: 19710010
Database Links

HGNC: 6255

OMIM: 241200

KEGG: hsa:3758

STRING: 9606.ENSP00000376432

UniGene: Hs.527830

Involvement In Disease
Bartter syndrome 2, antenatal (BARTS2)
Protein Families
Inward rectifier-type potassium channel (TC 1.A.2.1) family, KCNJ1 subfamily
Subcellular Location
Cell membrane; Multi-pass membrane protein. Note=Phosphorylation at Ser-44 by SGK1 is necessary for its expression at the cell membrane.
Tissue Specificity
In the kidney and pancreatic islets. Lower levels in skeletal muscle, pancreas, spleen, brain, heart and liver.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.